Treatment of fibrotic disease

Details for Australian Patent Application No. 2004269927 (hide)

Owner Merck Serono SA

Inventors Power, Christine; Lavrovsky, Yan

Agent Griffith Hack

Pub. Number AU-B-2004269927

PCT Pub. Number WO2005/023288

Priority 03102723.8 08.09.03 EP

Filing date 7 September 2004

Wipo publication date 17 March 2005

Acceptance publication date 17 September 2009

International Classifications

A61P 19/04 (2006.01) Drugs for skeletal disorders

A61K 38/19 (2006.01) Medicinal preparations containing peptides - Cytokines

C07K 14/52 (2006.01) Peptides having more than 20 amino acids

Event Publications

16 February 2006 PCT application entered the National Phase

  PCT publication WO2005/023288 Priority application(s): WO2005/023288

25 October 2007 Assignment before Grant

  Applied Research Systems ARS Holding N.V The application has been assigned to Laboratoires Serono SA

23 April 2009 Alteration of Name

  The name of the applicant has been altered to Merck Serono SA

17 September 2009 Application Accepted

  Published as AU-B-2004269927

21 January 2010 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004269930-Entry inhibitors of the HIV virus

2004269924-ERG channel openers for the treatment of cardiac arrhythmias